Literature DB >> 11106655

Mechanisms underlying preferential assembly of heparan sulfate on glypican-1.

R L Chen1, A D Lander.   

Abstract

Glypicans are major cell surface heparan sulfate proteoglycans, the structures of which are characterized by the presence of a cysteine-rich globular domain, a short glycosaminoglycan (GAG) attachment region, and a glycosylphosphatidylinositol membrane anchor. Despite strong evolutionary conservation of the globular domains of glypicans, no function has yet been attributed to them. By using a novel quantitative approach for assessing proteoglycan glycosylation, we show here that removal of the globular domain from rat glypican-1 converts the proteoglycan from one that bears approximately 90% heparan sulfate (HS) to one that bears approximately 90% chondroitin sulfate. Mutational analysis shows that sequences at least 70 amino acids away from the glypican-1 GAG attachment site are required for preferential HS assembly, although more nearby sequences also play a role. The effects of the glypican-1 globular domain on HS assembly could also be demonstrated by fusing this domain to sequences representing the GAG attachment sites of other proteoglycans or, surprisingly, simply by expressing the isolated globular domain in cells and analyzing effects either on an exogenously expressed glypican-1 GAG attachment domain or on endogenous proteoglycans. Quantitative analysis of the effect of the globular domain on GAG addition to proteoglycan core proteins suggested that preferential HS assembly is achieved, at least in part, through the inhibition of chondroitin sulfate assembly. These data identify the glypican-1 globular domain as a structural motif that potently influences GAG class determination and suggest that an important role of glypican globular domains is to ensure a high level of HS substitution of these proteoglycans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106655     DOI: 10.1074/jbc.M008283200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Glycans as receptors for influenza pathogenesis.

Authors:  Karthik Viswanathan; Aarthi Chandrasekaran; Aravind Srinivasan; Rahul Raman; V Sasisekharan; Ram Sasisekharan
Journal:  Glycoconj J       Date:  2010-08-24       Impact factor: 2.916

2.  Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells.

Authors:  Gui Su; Kristy Meyer; Chilkunda D Nandini; Dianhua Qiao; Shahriar Salamat; Andreas Friedl
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 3.  Shaping morphogen gradients by proteoglycans.

Authors:  Dong Yan; Xinhua Lin
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

4.  The tyrosine sulfate-rich domains of the LRR proteins fibromodulin and osteoadherin bind motifs of basic clusters in a variety of heparin-binding proteins, including bioactive factors.

Authors:  Viveka Tillgren; Patrik Onnerfjord; Lisbet Haglund; Dick Heinegård
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

5.  Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.

Authors:  B T Kim; H Kitagawa; J Tamura ; T Saito; M Kusche-Gullberg; U Lindahl; K Sugahara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 6.  Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.

Authors:  Andreas Friedl
Journal:  Semin Cell Dev Biol       Date:  2009-11-28       Impact factor: 7.727

Review 7.  Heparan sulfate biosynthesis: regulation and variability.

Authors:  Johan Kreuger; Lena Kjellén
Journal:  J Histochem Cytochem       Date:  2012-10-04       Impact factor: 2.479

8.  Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.

Authors:  Bowen Liu; Shirish Paranjpe; William C Bowen; Aaron W Bell; Jian-Hua Luo; Yan-Ping Yu; Wendy M Mars; George K Michalopoulos
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

Review 9.  Targeting angiogenesis in pancreatic cancer: rationale and pitfalls.

Authors:  Chery Whipple; Murray Korc
Journal:  Langenbecks Arch Surg       Date:  2008-01-22       Impact factor: 3.445

10.  Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.

Authors:  Takuma Aikawa; Chery A Whipple; Martha E Lopez; Jason Gunn; Alison Young; Arthur D Lander; Murray Korc
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.